Personalized Customer Service to Augment Outsourced Consumer Care Services Market By 2020

Global outsourced consumer care services market are expected to witness a significant growth over the forecast period owing to increased direct involvement of customers with the products and the companies. Today, various companies are trying their best to achieve higher-end user satisfaction.

In order to be in constant touch with their customers, companies make sure that they contact their existing and potential customers regularly to be able to know the needs and reviews about their products. This in turn needs to be done by a set of well-qualified customer care professionals who can cater to the customers in the best possible way. Companies have understood that providing the customers with an amazing experience can actually bring about a lot of difference to the business.

Customers are more connected to the business today, unlike the old days, which is a major reason for the growth of outsourced consumer care services market in the past few years. With the intention to modernize the customer experience, the companies have started focusing on customization and on increasing the involvement of customers in the business, products, and services.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/outsourced-customer-care-services-market

The current shift in the direction of cloud-based services is expected to assist companies and businesses to enter their respective markets. Also, the ability to reach the customers though mobile mediums and thus market their product has led to overall increase in the demand of global outsourced consumer care services market.

Improving the customer experience by offering personalized and customized interactions will lead to the overall increase in the outsourced customer care service market. Mobile customer service across different platforms, interaction via non-voice channels, and a transition in direction to host-based customer services in addition to social media and big data are expected to augment the global outsourced consumer care services market at a CAGR of 5.2% considering the forecast period from 2014 to 2020.

On the basis of services catered to, the global customer care market is segmented into customer relationship management, logistics, and customer interaction. Customer relationship management is all about managing and retaining existing customers and attracting potential customers in order to increase overall sales. Customer interaction is majorly used by companies to lure potential customers and engage the existing customers and it includes various activities including sales, customer care, marketing, product support, and technical support.

Various other activities included in outbound customer service are email & chat support, telemarketing, inbound & outbound calls, customer helpdesk, technical support, lead generation, billing, and collection. However, setting a dedicated customer service center is not only complex but incurs cost in recruitment, and hence, outsourcing the customer care services will provide better opportunities of gaining high customer satisfaction.

Many companies have taken the route of outsourcing, not only for providing customer support, but also for back-office duties like data processing and order management. Customer-driven services focus on aiding the customer with pre-sales and post-sales services to attain a higher customer retention rate in the rising competitive scenario. CRM enables the organizations to operate their key business areas and increase the return on investment.

Global outsourced customer care service market is segmented on the basis of regions into EMEA, South America, North America, and Asia Pacific. North America is expected to continue to be the largest regional market in the coming years. Mobility and communication channels are identified as the key factors leading to the growth of customer service market in North America.

Asia Pacific has been accounted the second largest region in the market due to its growth in mobile services market and wireless market .However, consumer’s concerns about data privacy and security may hamper the growth as they might prefer traditional customer care service over cloud-based or mobile services. Key players in the global outsourced customer care service market are Sykes Enterprises, Stream Global Services, Convergys Corporation, Teleperformance SA, and West Corporation.

Artificial Vital Organs & Medical Bionics Market Worth $45.9 Billion By 2022

The global artificial vital organs and medical bionics market is expected to reach USD 45.92 billion by 2022, according to a new report by Grand View Research Inc. Key growth drivers identified in the artificial vital organs market include increasing base of geriatric population suffering from chronic diseases such as cardiovascular and respiratory diseases leading to organ failures or damage.

Furthermore, the increasing number of patients suffering from physical disabilities such as loss of limbs and arms owing to congenital factors, accidents, serving in armed forces and industrial accidents is likely to positively reinforce medical bionics market growth over the forecast period.

The proliferation of universal health coverage schemes launched by various governments and increasing public and private reimbursement policy coverage are major trends expected to boost the usage rates of artificial vital organs and medical bionics in the next seven years.

The artificial vital organs market includes products such as artificial heart, pancreas, kidneys, and lungs. These are used for organ transplantation in patients suffering with organ damages or complete organ failures.

In 2014, artificial kidney market accounted for the largest market share of over 60% owing to increasing prevalence of high blood sugar, hypertension, post-surgery infections, glomerular diseases, injury or burns, HIV, and other risk factors.

Artificial liver is expected to be the fastest growing product segment growing at a lucrative rate over the forecast period of seven years. Key factors attributing to its rapid growth include increasing prevalence of chronic lung diseases such as COPD and disadvantages of using mechanical ventilators.

The medical bionics segment includes products such as brain, ear, vision bionics, exoskeleton, and bionic limbs. In 2014, brain bionics held the largest market share of nearly 41% due to the continually increasing number of patients suffering from neurological conditions. Furthermore, non-invasive nature of spinal cord stimulators, vagus nerve stimulators, and deep brain stimulators are key factors positively impacting market growth in the next seven years. Exoskeletons are likely to witness a rapid rise in demand owing to its wide applications in rescue, emergency response, home healthcare, and patient rehabilitation.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/artificial-vital-organs-and-medical-bionics-market

Further key findings from the report suggest:

  • North America accounted for the largest market share of over 40% in 2014 owing to increasing prevalence of geriatric population suffering with organ damages or failures coupled with increasing numbers of physically challenged persons opting to use prosthetic limbs due to rising awareness and better reimbursement policies for such procedures
  • Asia Pacific is expected to be the fastest growing market in the next seven-year period. Key factors contributing to growth in Asia Pacific are increase in public and private healthcare expenditure, penetration of healthcare insurance across urban and rural centers. Furthermore, increase in chronic diseases and increase in medical tourism are also expected to significantly boost the artificial vital organ transplant and medical bionics market over the forecast period.
  • The global vital organ transplant and medical bionics market is dominated by players such as Abiomed, Touch Bionics, Baxter, Medtronics, Ottobock Healthcare, and Heartware.

Transcriptomics Technologies Market Worth $6.9 Billion By 2022

The global transcriptomics technologies market is expected to reach USD 6.9 billion by 2022, according to a new report by Grand View Research Inc. The increasing demand for genetic identification and growing investment in R&D innovation along with the technological advancements across the product portfolio are the vital driving forces of this market. The increasing R&D investments are expected to highly influence biotechnological research and develop commercialization over the forecast period. The rising investment is further anticipated to ensure positive growth and enhance business opportunities for pharmaceutical and biotechnological companies. 

Furthermore, the rising demand for efficient diagnostic methods drives the need for personalized medicines. Transcriptomics tools and the offered services identify potential drug targets, which are effective methods for diagnostic methodologies. The shifting preference of pharmaceutical companies towards therapeutics results in rising demand for disease-specific biomarker identification. This change ensures a potential opportunity in the commercialization of transcriptome research results. The escalating demand for efficient diagnostics and treatment measures in the areas of oncology, HIV, Alzheimer’s disease, etc., also contributes significantly towards transcriptomics technologies market growth. 

Click the link below:
http://www.grandviewresearch.com/industry-analysis/transcriptomics-technologies-market

Further key findings from the report suggest:

  • Polymerase Chain Reaction (PCR) based transcriptomics technologies market is expected to account for over 40% market share by 2022 owing to its ability to enable amplification even from very small amounts of genetic material samples
  • Next-generation Sequencing based transcriptomics technologies market is expected to grow at a lucrative CAGR of over 17.0% over the forecast period owing to increased outsourcing of sequencing technologies, upgrading of technology enabling the analysis of cellular transcriptome from various dimensions, and wide application areas of NGS
  • North America dominates the transcriptomics technologies market in terms of revenue owing to the increasing R&D activities by the biotechnology and pharmaceutical companies
  • North America and Asia Pacific are expected to witness the fastest growth of over 15.0% during the forecast period. The growth is due to the presence of untapped opportunities, rising expenditure levels, and the introduction of favorable government initiatives.
  • Key players of transcriptomics technologies market include Agilent Technologies, Affymetrix, Thermo Fisher Scientific, Illumina, Life Technologies, and F. Hoffmann-La Roche
  • Market participants are constantly engaged in strategic collaborations such as mergers and acquisitions along with technological advancements in an attempt to improve presence and ensure sustainability
  • For instance, in May 2015, Agilent Technologies announced the acquisition of Cartagenia that provides services and software for clinical genetic analysis. Their products are supplied to pathology laboratories and clinical research institutes. The acquisition is expected to provide higher integration and support customer satisfaction. 

Commercial UAV Market Size To Reach $2.07 Billion By 2022

The global commercial UAV market size is expected to reach USD 2.07 billion by 2022, according to a new study by Grand View Research, Inc.

Increasing applications in agriculture and law enforcement are expected to drive the commercial UAV industry growth over the forecast period. Commercial drones are finding applications across various industry verticals globally. Every industrialized country in the world is making investments in drones, thus driving the scope and technological developments for applications in the commercial UAV market.

Drones are contemporary alternatives for activities, where human life cannot be risked. Such drones find applications in various industrial verticals including military, homeland security, retail, and agriculture. The demand is significantly higher for military applications, although commercial applications are progressively catching up.

Aviation regulatory bodies such as the Federal Aviation Administration (FAA) have imposed restrictions on the use of such drones taking into consideration the difficulties in managing such huge air traffic and the safety of the citizens. However, the FAA is known to be undertaking an initiative to accelerate the UAV approval process for public safety agencies and broaden access to civilian organizations for a variety of commercial, industrial, and other applications.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/commercial-uav-market

Further key findings from the study suggest:

  • Rotary blade drones accounted for over 70% of the global market share owing to their easy maneuverability and compact design. Moreover, such single and multi-rotor drones equipped with rotary blades have Vertical Take-Off and Landing (VTOL) abilities for applications, where there is limitation of space for fixed blade drones to take off. The development of advanced hybrid UAVs that operate on non-conventional sources of energy and nano, small miniature drones serve multiple applications across various industry verticals.
  • Government applications dominated the global commercial UAV industry constituting over 40% of the market share in 2014. Increasing applications in law enforcement, security and surveillance, R&D activities, infrastructure, disaster management, and environmental studies have led to an increased demand for such unmanned aerial vehicles from the concerned government agencies. Innovative applications across agricultural sector have made it the fastest growing application segment, which is projected to grow at a CAGR of over 18% from 2015 to 2022. Special agricultural drones can take snapshots of fields and help in analyzing crops. In addition, fix winged drones can be used for applications such as watering, spreading seeds, fertilizers, and pesticides over large farm fields that drastically reduce the time required and increase the efficiency.
  • North America is expected to grow at a CAGR of over 16% over the forecast period on account of concentration of major drone manufacturers and increasing applications in the commercial sectors in the region. Governments and technology giants across the world are striving hard to provide internet to the people as a basic necessity. Facebook Inc. recently acquired Ascenta, a drone manufacturer for its pilot project to provide internet in remote areas using drones as movable wireless access points. Relaxation in regulations and increasing use of drones in law enforcement activities in Europe have led to the regional industry growth.
  • Major industry participants include AeroVironment Inc., BAE Systems, DJI, Elbit Systems, Parrot SA, Israel Aerospace Industries, The Boeing Company, and Textron Inc. Manufacturers resort to mergers and acquisitions as their key growth strategy to make their presence felt in the industry. Augmented funding, technological collaborations, and government agencies are expected to emerge as critical success factors for industry growth.

Marine Propulsion Engines Market Is Expected to Reach USD 10.95 Billion by 2020

The Global Marine Propulsion Engines Market is expected to reach USD 10.95 billion by 2020, according to a new study by Grand View Research, Inc. Significant modernization in marine propulsion as a direct consequence of increased demand for operationally dependable and financially efficient ships is expected to drive the marine propulsion engines market. The shipping industry has started to focus more on reducing fossil fuel consumption by developing electric motors which also help increase energy efficiency.

The market is expected to be hindered by regulations of the International Convention for the Prevention of Pollution from Ships (MARPOL), which apply principally to the protection of the marine environment and prevention of contamination by oil, chemical spills, sewage, marine species, and air pollution by engine exhaust gases. With the advancement in technology and increasing awareness pertaining to environmental conservation, the development of propulsion systems that run on alternate fuels and with minimal emissions has garnered special importance.

Although wind and solar energy have gained prominence as auxiliary propulsion sources in the marine propulsion engines market, they are inadequate to suffice the power requirements for primary propulsion purposes.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/marine-propulsion-engines-market

Further key findings from the study suggest:

  • High reliability and easy operability have resulted in diesel engines being the most extensively used to meet the primary as well as auxiliary ship propulsion needs in the marine industry. The presence of well-established spare parts and repair networks globally coupled with the availability of trained engineers and established training facilities has further driven the diesel marine propulsion engine demand.
  • The depleting conventional and shale gas reserves have led to an increase in the demand for liquefied natural gas (LNG) as a marine fuel, which involves dual fuel diesel (DFD) engines as prime movers. Wind energy and solar energy have gained prominence as auxiliary power generating sources as they do not emit harmful pollutants. Although steam turbine systems were traditionally used as prime movers, they have been increasingly substituted by diesel and dual-fuel diesel (DFD) engines. Steam marine propulsion engines are still used in niche applications such as coal carriers and LNG carriers.
  • Asia Pacific accounted for a substantial share of the overall marine propulsion engine market revenue in 2013, which can be attributed to significant investments by countries in the Far East such as China and South Korea. North America is among the highest adopters of LNG as a propulsion medium.
  • Leading marine propulsion engine manufacturers such as Wärtsilä, Rolls-Royce, MAN Diesel, Caterpillar, and Cummins adopt global multi-sourcing strategies to explore alternative sources of supply. Marine propulsion engines manufacturers have dedicated professional sales staff having expertise in the company’s entire product lines for identifying specific and tailored solutions. The marine propulsion engines market is characterized by frequent mergers and acquisitions in a bid to achieve a competitive advantage.

Automotive lighting market to grow at 12.0% CAGR from 2015 to 2022

The automotive lighting market is anticipated to reach USD 34.65 billion by 2022. Strict government policies and rising safety concerns are likely to propel growth over the forecast period. In addition, growing consumer awareness concerning the significance of adaptive lighting including dynamic bend light and a glare-free high beam is also expected to have a positive impact on the exterior lighting market. 

Increasing apprehensions about using energy-efficient methods coupled with rising consumer disposable income are expected to drive the industry. In addition, growing demand for vehicles and technological advancements in the automotive industry is expected to propel utilization. Attractive growth opportunities for new entrants are expected in the industry owing to the growing number of total vehicles purchased y-o-y across BRIC nations. However, there is a need for legislative authorities to collaborate with light sourcing technology suppliers to develop flexible design techniques. 

THE Automotive LED market is estimated to demonstrate considerable growth at a CAGR of over 12.0% from 2015 to 2022. Halogen lights contributed to over 66.0% of overall industry revenue in 2014, followed by LED and xenon. It has gained prominence on account of easy availability, low purchasing costs, and low replacement costs. However, rising fuel prices are expected to pose a threat to the industry. 

Click the link below:
http://www.grandviewresearch.com/industry-analysis/automotive-lighting-market

The increase in demand for eco-friendly LED technologies on account of high efficiency, reduced CO2 levels, and high power, is expected to propel growth. Companies have been trying to develop eco-friendly LEDs to promote product differentiation and strengthen their global foothold. LEDs are used in daytime running lights (DRL), parking light, brake lights, and turning lights. LEDs are preferred over xenon and halogen lights owing to optimum light-bearing capacities and improved design, which lead to increased shelf life. 

The adaptive headlight is an active safety feature that is intended to enhance the drivers’ visibility in poorly illuminated areas. It encompasses functionalities including automatic rotation which can sync with sensors and adjust brightness and intensity of light. The front lighting segment accounted for over 70.0% of the total revenue in 2014 owing to the availability of advanced features including automatic rotation which can sync with automatic brightness modules and sensor response. Extreme climatic conditions in Europe and North America are expected to trigger demand for fog lights over the forecast period. 

The automotive lighting industry in Asia Pacific is estimated to grow at a CAGR of over 8.0% and acquire a market share of about 45.0% over the forecast period. The continuous expansion of suppliers coupled with a vast production base is expected to position this region as the market leader. Countries including India, Japan, and China account for the major production base for vehicles globally, thus offering extensive growth opportunities. 

Key companies including Hella KGaA Hueck & Co., Koito Manufacturing Co., Magneti Marelli S.p.A and Valeo. Vendors usually employ the strategy of new product development and mergers & acquisitions to enter new markets. The introduction of low-cost LEDs and energy-efficient alternatives is foreseen as a cost-effective strategy for the industry.

Pharmacy automation devices market to grow at 7.3% CAGR in 2020

Pharmacy automation involves automation and mechanization of tasks that include distribution and handling medication processes carried out in heath care centers and specialty pharmacy centers. The global pharmacy automation devices industry is projected to grow at a CAGR of 7.3% from 2014 to 2020 and reach over USD 8.99 billion.

Automation systems such as packaging and labeling systems, medication dispensing system, storage and retrieval systems, table-top counters and compounding systems are employed in order improve the efficacy of regular jobs within pharmacies. The market is expected to grow owing to features including system integration that increases productivity and time to clinicians for patient care, thereby lowering medication errors.

Rising demand for pharmaceutical products, progressively growing technology and demand for precise robotic equipment & tools to perform operations at a faster rate are expected to be the key factors for market growth. Untapped growth opportunities in countries such as Brazil, China, and India coupled with escalating demand for automation in pharmacy and healthcare operations is expected to drive growth over the forecast period.

The market was dominated by automated medication dispensing systems in 2013. It accounted for a share of over 47.8% owing to growing demand for accurate medication dispensing systems. Automated dispensing systems have the ability to reduce significantly error rates and the ability to dispense hands-free. They provide storage, recording of medication, distribution to resident care and computer controlled dispensation.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/pharmacy-automation-market

Automated compounding systems are anticipated to grow rapidly at a CAGR of 8.4% from 2014 to 2020 owing to an increasing demand for mixing of medication and substantial decrease in total time to complete a dose.

The existence of IT healthcare systems and high rate of penetration in healthcare and pharmaceutical units resulted in North America occupying the largest regional market in 2013. It accounted for about 54.8% of the market revenue. Increasing healthcare overheads and R&D relevant to pharmacy automation devices are few factors responsible for its market share.

Asia Pacific is likely to grow at a CAGR of over 9.0% during the forecast period and is the most lucrative regional markets majorly due to improving healthcare infrastructure in emerging economies of China and India. Easy access available to new entrants including multinational pharmaceutical companies and distributors in this region coupled with the introduction of healthcare reforms in these countries is expected to drive market growth.

Key industry players include AmerisourceBergen Corporation, CareFusion Corporation, Accu-Chart Healthcare, ForHealth Technologies, GSE Scale Systems, Fulcrum Inc,McKesson Corporation, Innovation PharmaAssist Robotics, Pearson Medical Technologies, Health Robotics SRL, Kirby Lester, MedDispence, Pyxis Pharmacy Automation Systems, Medacist, MTS Medication Technologies, OmnicellInc, Cerner Corporation, Rice Lake Weighing Systems, Baxter International Inc., Aesynt Inc., ScriptPro LLC, Parat Systems Pharmacy Automation, Yuyama Co. Ltd, Swisslog Holding Ltd,Talyst Inc. and ScriptPro LLC.

Home Energy Management Systems Market Worth $2 Billion By 2020

The global home energy management systems (HEMS) market is expected to exceed USD 2 billion by 2020, according to a new study by Grand View Research, Inc. Owing to increasing energy cost coupled with growing environmental concerns, energy management has emerged as a significant priority, which is expected to fuel the HEMS market. The need to conserve and optimize energy utilization is expected to serve as a key market driver. Increased connectivity and widespread adoption of smartphones is also expected to favorably impact the market growth. Energy management products demand has gained momentum over the last few years owing to use of variable pricing schemes offered by service providers. Favorable regulatory initiatives in the U.S. pertaining to energy conservation are expected to propel regional HEMS market growth.

High installation cost coupled with system complexity is expected to pose a challenge to market growth over the forecast period. Lack of consumer awareness regarding home energy management systems and the benefits they offer may also hinder the HEMS market. Technological proliferation along with decreased sensor and display costs, improved device-level information processing capability, and roll-out of smart utility meters provide avenues for market growth.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/smart-home-energy-management

Further key findings from the study suggest:

  • Wi-Fi emerged as the dominant segment in 2013; it is expected to continue accounting for considerable market share over the forecast period. ZigBee, a standard for wireless networks, is expected to be a high growth segment over the forecast period. This can be attributed to its ability to support needs of various utilities, government groups and product manufacturers.
  • The HEMS market is dominated by control devices and systems; these include thermostats, whole home lighting systems and home automation systems. Enabling technologies are expected to witness high growth over the next six years due to popularity of technologies such as home area network, ZigBee and sensing.
  • On account of favorable government initiatives and growing need to address issues related to aging infrastructure, North America is expected to emerge as the most dominant regional market over the forecast period. Smart meter mandates by utilities is primarily expected to drive the HEMS market in Europe.
  • Key market participants include Intel Corporation, Panasonic Corporation, Cisco Systems Inc, General Electric Co. and Honeywell International. Innovations and extensive product development are expected to be the key growth strategies over the forecast period.

Bioinformatics Market Size To Reach $13.47 Billion By 2020

The global bioinformatics market is expected to reach USD 13.47 billion by 2020 growing at an estimated CAGR of 21.2% from 2014 to 2020, according to a new report by Grand View Research, Inc. Growing clinical development of biopharmaceutical and increasing need for three-dimensional drug designing technology are expected to drive the market growth over the next five years.

Furthermore, the development of bioinformatics tools and analysis platforms coupled with the introduction of novel technologies are expected to be high impact rendering factors for the growth of this market. Increasing demand for faster development of novel API and biopharmaceuticals is also expected to enhance the growth of this industry.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/bioinformatics-industry

Growth in the number of research and development studies in various ‘-omics’ related segments and the need for integration of the large amounts of biological data generated from these studies are also expected to encourage industry players to develop faster, more efficient, and versatile bioinformatics software cum platforms for commercialization.

Bio-content processing accounted for over 47% of the revenue share in 2013. The presence of increasing market demand for genetic database management, and need for related sequence, structural and phylogenic analysis tools and software is the primary factor accounting for this large share.

Moreover, the sequence and structural analysis platform segment is expected to grow at the fastest CAGR of over 20% over the forecast period owing to the development of next-generation sequencing and expected reduction in the cost of whole genome exome sequencing. These factors are expected to have a significantly positive impact on the overall growth of this market in the next five years.

Chemo-informatics and genomics accounted for over 50% of revenue share in 2013. Growing demand for novel biomarkers for R&D of biosimilar drugs and biopharmaceuticals is expected to significantly enhance the market penetration over the forecast period.

Proteomic applications are expected to attract a considerable amount of R&D investment in the near future and witness lucrative growth over the forecast period. Developments in three-dimensional drug development technologies are further expected to boost the growth of this segment.

North America accounted for over 40% of the global revenue in 2013. Factors accounting for this large share include the presence of key pharmaceutical companies in the region, which are involved in the clinical development of novel APIs and biosimilar drugs. The presence of a technologically advanced healthcare R&D framework also enhances this region’s investment capabilities for the development of the aforementioned market segments.

Asia Pacific is expected to register the fastest CAGR over the forecast period owing to the presence of companies providing outsourcing services. Furthermore, the presence of high unmet industry needs is expected to be a major factor driving the growth of this region over the forecast period.

Key players in this industry include IBM Life Sciences, BIOVIA, Life Technologies Corporation, Agilent technologies, 3rd Millennium Inc., Celera Corporation, Affymetrix, BioWisdom Ltd., and Rosetta Biosoftware.

Atrial Fibrillation Market Analysis By Procedure And Segment Forecasts To 2020

The global atrial fibrillation market is expected to reach USD 16.17 billion by 2020. Rising occurrence of strokes, brain damage and atrial fibrillation owing to blood clots along with an increasing geriatric population is expected to drive industry growth. Technological advancements in the field of microwave catheter ablation and radiofrequency along with rising occurrence of diseases caused by lifestyle habits such as drinking and smoking are further expected to fuel growth. Moreover, increasing demand for smaller cardiac incisions, minimally invasive procedures and small recovery time post-surgery are projected to bolster growth. Also, global aging population combined with the changes in lifestyle increasing the risks of obesity and high blood pressure is likely to drive demand.

Pharmacological products accounted for over 50% market share in 2013. Low prices of these products along with increasing use of anti-coagulants as an add-on therapy to non-pharmacological procedures are expected to drive demand.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/atrial-fibrillation-treatment-industry

Further key findings from the report suggest:

  • North America accounted for over 40% of global revenue in 2013. High penetration of non-pharmacological procedure and sophisticated reimbursement frameworks has resulted in its substantial demand over the past few years. High patient awareness and healthcare expenditure levels also contributed significantly towards region growth.
  • Asia-Pacific is expected to witness substantial growth during the forecast period, growing at a CAGR of over 13% from 2015 to 2022. Rising demand for non-pharmacological treatments due to improvement in healthcare infrastructure, high disposable incomes, and growing patient awareness are a few factors accounting for its rapid growth.
  • Radiofrequency catheter ablation procedure segment is expected to be the fastest growing segment with a CAGR of over 12% over the forecast period. Technological advancements related to maneuverability which helps in making tight bends inside the heart, the optimal size of the lesion produced and lower time required to recover from of catheter ablation is expected to drive demand over the next seven years.
  • Maze surgery occupied the second largest share of non-pharmacological treatment market. It removes the need for life-long anti-coagulants based treatment while reducing the occurrence of strokes. Anti-coagulants held the dominant market share in pharmacological treatment market as it reduced the incidence of blood clots and strokes which in turn is likely to propel demand over the projected period.
  • Key industry players include Boston Scientific Corporation, St. Jude Medical Inc., Johnson & Johnson Ltd., Sanofi-Aventis, CardioFocus Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Corporation, Biosense Webster Inc., AtriCure Inc. and Endoscopic Technologies Inc. St. Jude Medical Inc. developed an Endosense’sTactiCath. The technology provides live feedback related to pressure applied during microwave catheter ablations and radiofrequency.